Records containing: Hepatitis C Virus Infection
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-04-13An Evaluation of Bemnifosbuvir-Ruzasvir (BEM/RZR) Versus Sofosbuvir-Velpatasvir (SOF/VEL) for the Treatment of Chronic Hepatitis C Virus (HCV) Infection in a Phase 3 Randomized, Controlled, Open-label Study
-
CLINICAL_TRIALS study record update · 2026-03-19Digital, Community-Led, Social Action Initiative to Reduce Opioid Vulnerability and HIV/HCV in Rural Areas of the Midwest and Appalachia
-
CLINICAL_TRIALS study record update · 2025-08-29Effects of GPS Tracking on Patient Adherence to Hepatitis C Treatment Among People Experiencing Unsheltered Homelessness
-
CLINICAL_TRIALS study record update · 2025-08-12Relinking Diagnosed But Untreated HCV Patients Back Into Care.
-
CLINICAL_TRIALS study record update · 2025-08-01Access to Hepatitis C Treatment in Cameroon: Comparison of a Simplified Test and Treat Strategy to a Standard Strategy
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2025-06-29Early Detection of Hepatitis C in Injection Drug Users
-
CLINICAL_TRIALS study record update · 2024-12-05Characterization of Immune Genotypes and Antibody Profiles to Foster the discoVERY of diagnosticbioMARKERS of Liver Cancer Development
-
CLINICAL_TRIALS study record update · 2024-08-27A Communication-Based Study Focused on Assessing and Improving Hepatitis C Screening Rates, As Well As Treatment Rates in Arizona as a Step Towards Disease Eradication
-
CLINICAL_TRIALS study record update · 2024-08-02Interventions to Curb Hepatitis C Reinfections Among Men Who Have Sex With Men
-
CLINICAL_TRIALS study record update · 2024-06-18Screening for Hepatitis c in People Who Inject Drugs in Armenia-Colombia
-
CLINICAL_TRIALS study record update · 2024-06-10Adult Screening for Hepatitis c and Linkage to Treatment in Hospitals in Colombia
-
CLINICAL_TRIALS study record update · 2023-10-04A Registry for Subjects With Cirrhosis Who Achieve a Sustained Virologic Response Following Treatment With a Sofosbuvir-Based Regimen Without Interferon for Chronic Hepatitis C Infection
-
CLINICAL_TRIALS study record update · 2023-07-17Establishment of Rapid Diagnostic Procedure of "HCV Single-sample Detection Platform" in China
-
CLINICAL_TRIALS study record update · 2023-05-18Clinical Trial to Evaluate Efficacy and Acceptance of a Telemedicine Based Programme to Treat Hepatitis C Among Patients at Drug Addiction Centers
-
CLINICAL_TRIALS study record update · 2023-04-06Implementation of a Simplified, Low-barrier Primary Care HCV Treatment Model for High Risk, High Prevalence Populations in Austin, Texas
-
CLINICAL_TRIALS study record update · 2023-01-27A Long Term Follow-up Registry for Adolescent and Pediatric Subjects Who Received a Gilead Hepatitis C Virus Direct Acting Antiviral (DAA) in Gilead-Sponsored Chronic Hepatitis C Infection Trials
-
CLINICAL_TRIALS study record update · 2023-01-23CARES-HCV: Promoting Concurrent Hepatitis C Virus Screening and Colorectal Cancer Screening Uptake Among Diverse Baby Boomers
-
CLINICAL_TRIALS study record update · 2022-08-23Pharmacokinetics of Sofosbuvir/Daclatasvir in HCV-infected Lactating Women: a Pilot Study
-
CLINICAL_TRIALS study record update · 2022-07-11Evaluation of the Safety and Effectiveness of Direct-acting Antiviral Drugs in the Treatment of Hepatitis C in Patients With Inflammatory Bowel Disease: National Multicenter Study (MIC Project).
-
CLINICAL_TRIALS study record update · 2022-06-08A Phase I/IIa Study Assessing AT-777 in Healthy Subjects and AT-777 in Combination With AT-527 in HCV-Infected Subjects
-
CLINICAL_TRIALS study record update · 2022-05-04An Open-Label, Multicenter Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Combination With Sofosbuvir and Ribavirin in Chronic Hepatitis C (HCV) Infected Subjects Who Have Experienced Virologic Failure in AbbVie HCV Clinical Studies (MAGELLAN-3)
-
CLINICAL_TRIALS study record update · 2022-04-27Pharmacist-led Hepatitis C Diagnosis and Rapid Management - in Community
-
CLINICAL_TRIALS study record update · 2022-04-20A Phase 3 Multicenter, Open-Label Study to Investigate the Efficacy and Safety of Sofosbuvir/Velpatasvir Fixed-Dose Combination for 12 Weeks in Subjects With Chronic HCV Infection and Compensated Cirrhosis
-
CLINICAL_TRIALS study record update · 2021-11-01Sofosbuvir/Velpatasvir/Voxilaprevir (SOF/VEL/VOX) for Patients With Hepatitis C Virus Infection: Real-world Effectiveness and Safety in Taiwan
-
CLINICAL_TRIALS study record update · 2021-10-27A Phase 3b Multicenter, Open-Label Study to Investigate the Efficacy and Safety of Sofosbuvir/Velpatasvir Fixed-Dose Combination and Sofosbuvir/Velpatasvir/Voxilaprevir Fixed-Dose Combination for 12 Weeks in Subjects With Chronic HCV Infection